Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Department of Public Health and Community Medicine, University of Gothenburg, Gothenburg, Sweden.
Mediators Inflamm. 2018 Jun 10;2018:3972104. doi: 10.1155/2018/3972104. eCollection 2018.
Glucocorticoid receptor (GR) function may have aetiopathogenic significance in chronic fatigue syndrome (CFS), via its essential role in mediating inflammatory responses as well as in hypothalamic-pituitary-adrenal axis regulation. GR function can be estimated ex vivo by measuring dexamethasone (dex) modulation of cytokine response to lipopolysaccharide (LPS), and using the impact of dex on cortisol levels. This study aimed to compare the GR function between CFS ( = 48), primary Sjögren's syndrome (a disease group control) ( = 27), and sedentary healthy controls (HCs) ( = 20), and to investigate its relationship with clinical measures. In the GR ex vivo response assay, whole blood was diluted and incubated with LPS (to stimulate cytokine production), with or without 10 or 100 nanomolar concentrations of dex. Cytometric bead array (CBA) and flow cytometry enabled quantification of cytokine levels (TNF, interleukin- (IL-) 6, and IL-10) in the supernatants. In the response assay, five plasma samples were taken for determination of total cortisol concentration using ELISA at half-hourly intervals on two consecutive mornings separated by ingestion of 0.5 mg of dex at 11 pm. The association of the data from the and ex vivo analyses with reported childhood adversity was also examined. CFS patients had reduced LPS-induced IL-6 and TNF production compared to both control groups and reduced suppression of TNF by the higher dose of dex compared to HCs. Cortisol levels, before or after dex, did not differ between CFS and HCs. Cortisol levels were more variable in CFS than HCs. In the combined group (CFS plus HC), cortisol concentrations positively and ex vivo GR function (determined by dex-mediated suppression of IL-10) negatively correlated with childhood adversity score. The results do not support the hypothesis that GR dysregulation is aetiopathogenic in CFS and suggest that current and future endocrine cross-sectional studies in CFS may be vulnerable to the confounding influence of childhood trauma which is likely increased by comorbid depression.
糖皮质激素受体 (GR) 功能在慢性疲劳综合征 (CFS) 中可能具有病因学意义,因为它在介导炎症反应以及调节下丘脑-垂体-肾上腺轴方面发挥着重要作用。GR 功能可以通过测量地塞米松 (dex) 对脂多糖 (LPS) 反应中细胞因子的调节作用以及 dex 对皮质醇水平的影响来在体外进行评估。本研究旨在比较 CFS(n = 48)、原发性干燥综合征(一种疾病对照组)(n = 27)和久坐健康对照组(HCs)(n = 20)之间的 GR 功能,并探讨其与临床指标的关系。在 GR 体外反应测定中,将全血稀释并与 LPS(刺激细胞因子产生)孵育,有或没有 10 或 100 纳摩尔浓度的 dex。通过细胞因子珠阵列(CBA)和流式细胞术可以定量上清液中细胞因子水平(TNF、白细胞介素-(IL-)6 和 IL-10)。在反应测定中,在连续两天的早上,分别在晚上 11 点服用 0.5 毫克 dex 后,每隔半小时采集五次血浆样本,使用 ELISA 测定总皮质醇浓度。还检查了体外和体外分析数据与报告的儿童期逆境的关联。与两个对照组相比,CFS 患者的 LPS 诱导的 IL-6 和 TNF 产生减少,与 HCs 相比,较高剂量的 dex 对 TNF 的抑制作用减少。CFS 和 HCs 之间在服用 dex 前后的皮质醇水平没有差异。CFS 患者的皮质醇水平比 HCs 更具可变性。在合并组(CFS 加 HCs)中,皮质醇浓度与儿童期逆境评分呈正相关,而体外 GR 功能(由 dex 介导的 IL-10 抑制来确定)呈负相关。结果不支持 GR 失调是 CFS 病因学的假设,并表明 CFS 中当前和未来的内分泌横断面研究可能容易受到童年创伤的混杂影响,而合并抑郁症的可能性会增加这种影响。